Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 2005 (2), 63-80

Antiinflammatory and Immunomodulating Properties of Fungal Metabolites


Antiinflammatory and Immunomodulating Properties of Fungal Metabolites

Cristina Lull et al. Mediators Inflamm.


We discuss current information on the ability of extracts and isolated metabolites from mushrooms to modulate immune responses. This can result in a more enhanced innate and acquired disease resistance. The major immunomodulating effects of these active substances derived from mushrooms include mitogenicity and activation of immune effector cells, such as lymphocytes, macrophages, and natural killer cells, resulting in the production of cytokines, including interleukins (ILs), tumor necrosis factor alpha (TNF)-alpha, and interferon gamma (INF)-gamma. In particular, the ability of selective mushroom extracts to modulate the differentiation capacity of CD4(+) T cells to mature into T(H)1 and/or T(H)2 subsets will be discussed. As a consequence these extracts will have profound effects in particular diseases, like chronic autoimmune T(H)1-mediated or allergic T(H)2-mediated diseases. Immunosuppressive effects by mushroom components have also been observed. The therapeutic effects of mushrooms, such as anticancer activity, suppression of autoimmune diseases, and allergy have been associated with their immunomodulating effects. However, further studies are needed to determine the molecular mechanisms of the immunomodulating effects of mushrooms metabolites both individually and in complex mixtures, for example, extracts.


Figure 1
Figure 1
Diagrammatic representation of mushroom life cycle.
Figure 2
Figure 2
Repeating unit of immunomodulatory β-glucans (a) from Grifola frondosa (D-fraction, MW: 1000 kD) and (b) from L edodes (lentinan, MW: 500 kD).
Figure 3
Figure 3
Schematic representation of the possible targets of the adaptive immune system for mushroom ingredients with immunomodulatory properties. APC: antigen-presenting cell; FcR: Fc receptor; TLR: Toll-like receptor; CR1: complement receptor type 1; C': activated complement; GSH: glutathione; MHC II: major histocompatibility complex class II; TCR: T-cell receptor; TH: helper T cells; TC: cytotoxic T lymphocytes; TR: regulatory T cells; NO: nitric oxide; IL-4: interleukin-4; IL-4R: interleukin-4 receptor; CD: cluster designation.

Similar articles

See all similar articles

Cited by 39 articles

See all "Cited by" articles


    1. Chang R. Functional properties of edible mushrooms. Nutr Rev. 1996;54(pt 2):S91–S93. - PubMed
    1. Wasser SP, Weis AL. Therapeutic effects of substances occurring in higher basidiomycetes mushrooms: a modern perspective. Crit Rev Immunol. 1999;19(1):65–96. - PubMed
    1. Reshetnikov SV, Wasser SP, Tan KK. Higher basidiomycota as a source of antitumor and immunostimulating polysaccharides. Int J Med Mushr. 2001;3(4):361–394.
    1. Wasser SP. Medicinal mushrooms as a source of antitumor and immunomodulating polysaccharides. Appl Microbiol Biotechnol. 2002;60(3):258–274. - PubMed
    1. Borchers AT, Stern JS, Hackman RM, Keen CL, Gershwin ME. Mushrooms, tumors, and immunity. Proc Soc Exp Biol Med. 1999;221(4):281–293. - PubMed

Publication types

MeSH terms